1 Study Coverage 1.1 Anti-Venom Product Introduction 1.2 Global Anti-Venom Outlook 2017 VS 2022 VS 2028 1.2.1 Global Anti-Venom Sales in US$ Million for the Year 2017-2028 1.2.2 Global Anti-Venom Sales in Volume for the Year 2017-2028 1.3 United States Anti-Venom Outlook 2017 VS 2022 VS 2028 1.3.1 United States Anti-Venom Sales in US$ Million for the Year 2017-2028 1.3.2 United States Anti-Venom Sales in Volume for the Year 2017-2028 1.4 Anti-Venom Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Anti-Venom in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Anti-Venom Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Anti-Venom Market Dynamics 1.5.1 Anti-Venom Industry Trends 1.5.2 Anti-Venom Market Drivers 1.5.3 Anti-Venom Market Challenges 1.5.4 Anti-Venom Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Anti-Venom Market Segment by Type 2.1.1 Polyvalent Anti-Venom 2.1.2 Monovalent Anti-Venom 2.2 Global Anti-Venom Market Size by Type 2.2.1 Global Anti-Venom Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Anti-Venom Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Anti-Venom Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Anti-Venom Market Size by Type 2.3.1 United States Anti-Venom Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Anti-Venom Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Anti-Venom Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Anti-Venom Market Segment by Application 3.1.1 Non-profit Institutions 3.1.2 Hospitals and Clinic 3.2 Global Anti-Venom Market Size by Application 3.2.1 Global Anti-Venom Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Anti-Venom Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Anti-Venom Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Anti-Venom Market Size by Application 3.3.1 United States Anti-Venom Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Anti-Venom Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Anti-Venom Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Anti-Venom Competitor Landscape by Company 4.1 Global Anti-Venom Market Size by Company 4.1.1 Top Global Anti-Venom Manufacturers Ranked by Revenue (2021) 4.1.2 Global Anti-Venom Revenue by Manufacturer (2017-2022) 4.1.3 Global Anti-Venom Sales by Manufacturer (2017-2022) 4.1.4 Global Anti-Venom Price by Manufacturer (2017-2022) 4.2 Global Anti-Venom Concentration Ratio (CR) 4.2.1 Anti-Venom Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Anti-Venom in 2021 4.2.3 Global Anti-Venom Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Anti-Venom Manufacturing Base Distribution, Product Type 4.3.1 Global Anti-Venom Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Anti-Venom Product Type 4.3.3 Date of International Manufacturers Enter into Anti-Venom Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Anti-Venom Market Size by Company 4.5.1 Top Anti-Venom Players in United States, Ranked by Revenue (2021) 4.5.2 United States Anti-Venom Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Anti-Venom Sales by Players (2020, 2021 & 2022) 5 Global Anti-Venom Market Size by Region 5.1 Global Anti-Venom Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Anti-Venom Market Size in Volume by Region (2017-2028) 5.2.1 Global Anti-Venom Sales in Volume by Region: 2017-2022 5.2.2 Global Anti-Venom Sales in Volume Forecast by Region (2023-2028) 5.3 Global Anti-Venom Market Size in Value by Region (2017-2028) 5.3.1 Global Anti-Venom Sales in Value by Region: 2017-2022 5.3.2 Global Anti-Venom Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Anti-Venom Market Size YoY Growth 2017-2028 6.1.2 North America Anti-Venom Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Anti-Venom Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Anti-Venom Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Anti-Venom Market Size YoY Growth 2017-2028 6.3.2 Europe Anti-Venom Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Anti-Venom Market Size YoY Growth 2017-2028 6.4.2 Latin America Anti-Venom Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Anti-Venom Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Anti-Venom Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 CSL 7.1.1 CSL Corporation Information 7.1.2 CSL Description and Business Overview 7.1.3 CSL Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.1.4 CSL Anti-Venom Products Offered 7.1.5 CSL Recent Development 7.2 Merck 7.2.1 Merck Corporation Information 7.2.2 Merck Description and Business Overview 7.2.3 Merck Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Merck Anti-Venom Products Offered 7.2.5 Merck Recent Development 7.3 BTG 7.3.1 BTG Corporation Information 7.3.2 BTG Description and Business Overview 7.3.3 BTG Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.3.4 BTG Anti-Venom Products Offered 7.3.5 BTG Recent Development 7.4 Pfizer 7.4.1 Pfizer Corporation Information 7.4.2 Pfizer Description and Business Overview 7.4.3 Pfizer Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Pfizer Anti-Venom Products Offered 7.4.5 Pfizer Recent Development 7.5 Haffkine Bio-Pharmaceutical 7.5.1 Haffkine Bio-Pharmaceutical Corporation Information 7.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview 7.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Products Offered 7.5.5 Haffkine Bio-Pharmaceutical Recent Development 7.6 Rare Disease Therapeutics 7.6.1 Rare Disease Therapeutics Corporation Information 7.6.2 Rare Disease Therapeutics Description and Business Overview 7.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Rare Disease Therapeutics Anti-Venom Products Offered 7.6.5 Rare Disease Therapeutics Recent Development 7.7 Flynn Pharma 7.7.1 Flynn Pharma Corporation Information 7.7.2 Flynn Pharma Description and Business Overview 7.7.3 Flynn Pharma Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Flynn Pharma Anti-Venom Products Offered 7.7.5 Flynn Pharma Recent Development 7.8 Vins Bioproducts 7.8.1 Vins Bioproducts Corporation Information 7.8.2 Vins Bioproducts Description and Business Overview 7.8.3 Vins Bioproducts Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Vins Bioproducts Anti-Venom Products Offered 7.8.5 Vins Bioproducts Recent Development 7.9 Bharat Serums and Vaccines 7.9.1 Bharat Serums and Vaccines Corporation Information 7.9.2 Bharat Serums and Vaccines Description and Business Overview 7.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Bharat Serums and Vaccines Anti-Venom Products Offered 7.9.5 Bharat Serums and Vaccines Recent Development 7.10 Serum Biotech 7.10.1 Serum Biotech Corporation Information 7.10.2 Serum Biotech Description and Business Overview 7.10.3 Serum Biotech Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Serum Biotech Anti-Venom Products Offered 7.10.5 Serum Biotech Recent Development 7.11 MicroPharm 7.11.1 MicroPharm Corporation Information 7.11.2 MicroPharm Description and Business Overview 7.11.3 MicroPharm Anti-Venom Sales, Revenue and Gross Margin (2017-2022) 7.11.4 MicroPharm Anti-Venom Products Offered 7.11.5 MicroPharm Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Anti-Venom Industry Chain Analysis 8.2 Anti-Venom Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Anti-Venom Distributors 8.3 Anti-Venom Production Mode & Process 8.4 Anti-Venom Sales and Marketing 8.4.1 Anti-Venom Sales Channels 8.4.2 Anti-Venom Distributors 8.5 Anti-Venom Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Anti-Venom CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Anti-Venom Market Trends Table 3. Anti-Venom Market Drivers Table 4. Anti-Venom Market Challenges Table 5. Anti-Venom Market Restraints Table 6. Global Anti-Venom Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Anti-Venom Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Anti-Venom Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Anti-Venom Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Anti-Venom Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Anti-Venom Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Anti-Venom Revenue Share by Manufacturer, 2017-2022 Table 13. Global Anti-Venom Sales by Manufacturer, (K Vials), 2017-2022 Table 14. Global Anti-Venom Sales Share by Manufacturer, 2017-2022 Table 15. Global Anti-Venom Price by Manufacturer (2017-2022) & (USD/Vial) Table 16. Global Anti-Venom Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Anti-Venom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Venom as of 2021) Table 18. Top Players of Anti-Venom in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Anti-Venom Product Type Table 20. Date of International Manufacturers Enter into Anti-Venom Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Anti-Venom Players in United States Market, Ranking by Revenue (2021) Table 23. United States Anti-Venom Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Anti-Venom Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Anti-Venom Sales by Players, (K Vials), 2020, 2021 & 2022 Table 26. United States Anti-Venom Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Anti-Venom Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Anti-Venom Sales in Volume by Region (2017-2022) & (K Vials) Table 29. Global Anti-Venom Sales in Volume Forecast by Region (2023-2028) & (K Vials) Table 30. Global Anti-Venom Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Anti-Venom Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Anti-Venom Sales in Volume by Country (2017-2028) & (K Vials) Table 33. North America Anti-Venom Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Anti-Venom Sales in Volume by Region (2017-2028) & (K Vials) Table 35. Asia Pacific Anti-Venom Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Anti-Venom Sales in Volume by Country (2017-2028) & (K Vials) Table 37. Europe Anti-Venom Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Anti-Venom Sales in Volume by Country (2017-2028) & (K Vials) Table 39. Latin Americaa Anti-Venom Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Anti-Venom Sales in Volume by Country (2017-2028) & (K Vials) Table 41. Middle East and Africa Anti-Venom Sales in Value by Country (2017-2028) & (US$ Million) Table 42. CSL Corporation Information Table 43. CSL Description and Business Overview Table 44. CSL Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 45. CSL Anti-Venom Product Table 46. CSL Recent Development Table 47. Merck Corporation Information Table 48. Merck Description and Business Overview Table 49. Merck Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 50. Merck Product Table 51. Merck Recent Development Table 52. BTG Corporation Information Table 53. BTG Description and Business Overview Table 54. BTG Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 55. BTG Product Table 56. BTG Recent Development Table 57. Pfizer Corporation Information Table 58. Pfizer Description and Business Overview Table 59. Pfizer Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 60. Pfizer Product Table 61. Pfizer Recent Development Table 62. Haffkine Bio-Pharmaceutical Corporation Information Table 63. Haffkine Bio-Pharmaceutical Description and Business Overview Table 64. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 65. Haffkine Bio-Pharmaceutical Product Table 66. Haffkine Bio-Pharmaceutical Recent Development Table 67. Rare Disease Therapeutics Corporation Information Table 68. Rare Disease Therapeutics Description and Business Overview Table 69. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 70. Rare Disease Therapeutics Product Table 71. Rare Disease Therapeutics Recent Development Table 72. Flynn Pharma Corporation Information Table 73. Flynn Pharma Description and Business Overview Table 74. Flynn Pharma Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 75. Flynn Pharma Product Table 76. Flynn Pharma Recent Development Table 77. Vins Bioproducts Corporation Information Table 78. Vins Bioproducts Description and Business Overview Table 79. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 80. Vins Bioproducts Product Table 81. Vins Bioproducts Recent Development Table 82. Bharat Serums and Vaccines Corporation Information Table 83. Bharat Serums and Vaccines Description and Business Overview Table 84. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 85. Bharat Serums and Vaccines Product Table 86. Bharat Serums and Vaccines Recent Development Table 87. Serum Biotech Corporation Information Table 88. Serum Biotech Description and Business Overview Table 89. Serum Biotech Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 90. Serum Biotech Product Table 91. Serum Biotech Recent Development Table 92. MicroPharm Corporation Information Table 93. MicroPharm Description and Business Overview Table 94. MicroPharm Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 95. MicroPharm Product Table 96. MicroPharm Recent Development Table 97. Key Raw Materials Lists Table 98. Raw Materials Key Suppliers Lists Table 99. Anti-Venom Customers List Table 100. Anti-Venom Distributors List Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Anti-Venom Product Picture Figure 2. Global Anti-Venom Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Anti-Venom Market Size 2017-2028 (US$ Million) Figure 4. Global Anti-Venom Sales 2017-2028 (K Vials) Figure 5. United States Anti-Venom Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Anti-Venom Market Size 2017-2028 (US$ Million) Figure 7. United States Anti-Venom Sales 2017-2028 (K Vials) Figure 8. United States Anti-Venom Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Anti-Venom Market Share in Global, in Volume (K Vials) 2017-2028 Figure 10. Anti-Venom Report Years Considered Figure 11. Product Picture of Polyvalent Anti-Venom Figure 12. Product Picture of Monovalent Anti-Venom Figure 13. Global Anti-Venom Market Share by Type in 2022 & 2028 Figure 14. Global Anti-Venom Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Anti-Venom Sales Market Share in Value by Type (2017-2028) Figure 16. Global Anti-Venom Sales by Type (2017-2028) & (K Vials) Figure 17. Global Anti-Venom Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Anti-Venom Price by Type (2017-2028) & (USD/Vial) Figure 19. United States Anti-Venom Market Share by Type in 2022 & 2028 Figure 20. United States Anti-Venom Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Anti-Venom Sales Market Share in Value by Type (2017-2028) Figure 22. United States Anti-Venom Sales by Type (2017-2028) & (K Vials) Figure 23. United States Anti-Venom Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Anti-Venom Price by Type (2017-2028) & (USD/Vial) Figure 25. Product Picture of Non-profit Institutions Figure 26. Product Picture of Hospitals and Clinic Figure 27. Global Anti-Venom Market Share by Application in 2022 & 2028 Figure 28. Global Anti-Venom Sales in Value by Application (2017-2028) & (US$ Million) Figure 29. Global Anti-Venom Sales Market Share in Value by Application (2017-2028) Figure 30. Global Anti-Venom Sales by Application (2017-2028) & (K Vials) Figure 31. Global Anti-Venom Sales Market Share in Volume by Application (2017-2028) Figure 32. Global Anti-Venom Price by Application (2017-2028) & (USD/Vial) Figure 33. United States Anti-Venom Market Share by Application in 2022 & 2028 Figure 34. United States Anti-Venom Sales in Value by Application (2017-2028) & (US$ Million) Figure 35. United States Anti-Venom Sales Market Share in Value by Application (2017-2028) Figure 36. United States Anti-Venom Sales by Application (2017-2028) & (K Vials) Figure 37. United States Anti-Venom Sales Market Share in Volume by Application (2017-2028) Figure 38. United States Anti-Venom Price by Application (2017-2028) & (USD/Vial) Figure 39. North America Anti-Venom Sales in Volume Growth Rate 2017-2028 (K Vials) Figure 40. North America Anti-Venom Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 41. U.S. Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 42. Canada Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Europe Anti-Venom Sales in Volume Growth Rate 2017-2028 (K Vials) Figure 44. Europe Anti-Venom Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 45. Germany Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. France Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. U.K. Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. Italy Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Russia Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Asia-Pacific Anti-Venom Sales in Volume Growth Rate 2017-2028 (K Vials) Figure 51. Asia-Pacific Anti-Venom Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 52. China Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Japan Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. South Korea Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. India Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Australia Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Taiwan Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Indonesia Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Thailand Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Malaysia Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Philippines Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Latin America Anti-Venom Sales in Volume Growth Rate 2017-2028 (K Vials) Figure 63. Latin America Anti-Venom Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 64. Mexico Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Brazil Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Argentina Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Middle East & Africa Anti-Venom Sales in Volume Growth Rate 2017-2028 (K Vials) Figure 68. Middle East & Africa Anti-Venom Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 69. Turkey Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Saudi Arabia Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. UAE Anti-Venom Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Anti-Venom Value Chain Figure 73. Anti-Venom Production Process Figure 74. Channels of Distribution Figure 75. Distributors Profiles Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

CSL Merck BTG Pfizer Haffkine Bio-Pharmaceutical Rare Disease Therapeutics Flynn Pharma Vins Bioproducts Bharat Serums and Vaccines Serum Biotech MicroPharm